on the heart are exerted both directly at the cellular level and by indirect interactions with the renin-angiotensin system (RAS), sympathetic nervous system (SNS) [2] and vascular smooth muscle [4, 5] , which lead to increased plasma volume, cardiac preload and, finally, cardiac output [1] . Although enhanced cardiac function is the most recognized outcome of hyperthyroidism, heart failure can occur even in young patients with hyperthyroidism in the absence of known heart disease and atrial fibrillation (AF) [6] [7] [8] . A recent study indicated decline cardiac function that begins after 4 weeks of TH treatment [9] . Interestingly, restoring normal levels of TH often reverses the cardiac dilatation and dysfunction, making hyperthyroid cardiomyopathy
Experimental design
A rat model of thyrotoxicosis was induced by daily intraperitoneal injections of T 4 (100 µg/kg/day) for 28 days as previously described [14] . Forty SpragueDawley rats were randomly divided into four groups (n=10 each): control group, T 4 group (T 4 alone), T 4 plus irbesartan group (30 mg/kg/day irbesartan, T 4 -Irb) and T 4 plus propranolol group (0.5mg/mL of drinking water, T 4 -Pro). Control rats received daily intraperitoneal administration of normal saline. Irbesartan was administrated in drinking water once a day during the 28 days of treatment. At the end of the treatments, serum T 3 , free T 4 and thyroid stimulating hormone (TSH) concentrations were measured using a competitive inhibition enzyme immunoassay kit (CUSABIO Biotech, Hubei, China). All rats underwent strain echocardiography and cardiac chamber size measurements, and hearts were removed. In the five rats in each group, hearts were sectioned transversely and slices were snap-frozen or immersion-fixed in 10% formalin for pathological analysis. Isolated cell aliquots were fixed in glutaraldehyde (myocyte length measurements, 40 cells/heart), then cardiomyocyte diameter and cardiac fibrosis were measured.
Hemodynamic parameters
In all rats, body weight (BW), systolic blood pressure (SBP) and heart rate (HR) were measured weekly at approximately the same time of day by tail-cuff plethysmograph (Kent Scientific, Orlando, FL, USA). Rats were familiarized with the apparatus for a total of 7 days before measurements were taken.
Echocardiography
Echocardiography was performed in animals just before they were sacrificed. Animals were anesthetized by an intraperitoneal injection of pentobarbital sodium (50 mg/kg). The chest was shaved, and the animals were placed on a warming pad to maintain normal body temperature. Echocardiographic gel was applied to the left hemithorax and examination was performed using a 15 MHz transducer on a Vivid 7 Dimension ultrasound apparatus (General Electric, Horten, Norway). The transducer was lightly placed on the left hemithorax and twodimensionally targeted M-mode echocardiograms were obtained from short-axis views of the left ventricle (LV) at the level of the papillary muscle tips and apical 4-chamber view with a frame rate of 250-300/s. LV end-diastolic septal and posterior wall thickness (IVSd and PWTd, respectively), LV end diastolic dimension (LVEDD) and a potentially curable form of heart failure [8] . However, whether cardiomyopathy in hyperthyroidism is due to direct toxic effects of the TH or due to tarchycardiainduced is still the subject of ongoing debate [10] .
Based on the clinical findings of hyperthyroidism such as increased heart rate, cardiac output, and enhanced myocardial contractility, hyperthyroidism is a hyperadrenergic state that may cause myocardial hypertrophy [11] . However, there are also conflicting reports regarding the preventative nature of sympathetic inhibition in TH-induced cardiac hypertrophy [12, 13] . TH directly stimulates renin mRNA in vivo [13, 14] and in vitro [15] , and increases both the synthesis and secretion of angiotensinogen and angiotensin (ANG) II receptors [16] . Also, TH activates circulating and tissue RAS without involving the SNS, and this may account for the cardiac hypertrophy observed in hyperthyroidism [14, 17] . These findings suggest that TH-induced cardiac hypertrophy could be involved in changes in circulating RAS or SNS activity, and these remodeling would be the cause of heart failure. However, it has yet to be established whether the impact of high output state with augmented HR or activated RAS contributes to TH-induced heart failure. This study investigated the effects of irbesartan, a RAS blocking agent, and propranolol, which blocks β-adrenoceptors, on TH-induced cardiac functional and structural remodeling by strain echocardiography and pathological analysis.
Materials and Methods

Animal models
Animal procedures were performed according to National Institutes of Health guidelines. The study protocol was approved by the Ethical Committee of Pusan National University Hospital. Healthy male SpragueDawley rats weighing 180-200 grams were obtained from the Japan SLC (Hamamatsu, Japan). Animals were housed in plastic cages (five animals each) with ad libitum access to water and standard rat chow. They were maintained under standard laboratory conditions (controlled temperature of 21-24°C, controlled light cycle consisting of alternating 12 hour periods of light and darkness) during all experiments. Levo-thyroxine (T 4 ) was purchased from Sigma-Aldrich (St. Louis, MO, USA). Blood pressure was assessed by a tail-cuff in conscious rats before each experiment.
LV end systolic dimension (LVESD) were measured. The LV fractional shortening (FS) was calculated according to the following formula: FS (%) = (LVEDD -LVESD) ÷ LVEDD. The mitral inflow velocity was measured by pulsed wave Doppler with a sample volume 2 mm from the apical 4-chamber at a sweep speed of 100 mm/s. The following measurements of LV diastolic function were determined: peak early (E) and late (A) diastolic mitral flow velocity and deceleration time of the E wave (DT), peak early (Ea) diastolic mitral annular velocity.
Strain echocardiography
Three heart beats were collected from each view and LV images sampled at appropriate frame rate of 80-150/s were post processed using the speckle tracking echocardiography software (Echopac 6.0.0; General Electric). Briefly, the displacement of speckles of LV myocardium (the acoustic markers) in each spot was tracked from frame-to-frame in each of the apical views. The software package then automatically tracked the motion through the rest of the cardiac cycle, providing the LV strain (%) profile by default. Peak LV longitudinal strain (S long ) was collected from the apical 4-chamber view (Fig. 1A) . The peak systolic LA strain was obtained from the basal segment of the inter-atrial septum in the apical 4-chamber view by the tissue Doppler strain (TDI) (Fig. 1B) . For the longitudinal measurements, a computation area of 1 x 0.5 mm with an elliptical shape was chosen.
Heart preparation
After echocardiography, the thorax of each animal was opened. Cardiac arrest was induced by injection of 14 mM potassium chloride. The heart was then quickly removed, blotted and weighed. The ventricles were carefully dissected, weighed, fixed in 10% neutral formalin and prepared for microscopic analysis.
Microscopic studies
The left ventricle was transversely sectioned at the midportion between the apex and base. A cross-sectional slice was removed and fixed in 10% neutral formalin at room temperature for 48-72 h. The slice was dehydrated in an increasing alcohol series, immersed in benzene for 20 min, and embedded in paraffin. All the microscopic fields were examined, and width of cardiomyocytes was measured using ocular micrometer. Five hundred cardiomyocytes were examined in five different fields. Apoptosis and necrosis, presence of fat droplet and inflammation of cardiomyocytes were evaluated on hematoxylin and eosin stain findings. To identify possible interstitial fibrosis, Masson-Trichrome staining was carried out in a NexES Special Stainer (Ventana Medial Systems, Tucson, AR, USA). Each 4 µm-thick section from five rats in each group was put in the stainer and Trichrome Blue kit was applied (Ventana Medial Systems).
Statistical analyses
The statistical analyses were performed using the SPSS version 15.0 package program (SPSS, Chicago, IL, USA). 
Echocardiography
Ventricular geometric patterns
The results of 2-dimensional echocardiographic examination are shown in Table 2 . T 4 alone showed significantly increased LVESD, IVSd and LA diameter (Fig. 2) without change of LVEDD, PWTd and relative wall thickness (RWT) compared with control. Interestingly, there were two rats in the T 4 alone that displayed significantly increased LVEDD and LVESD (7.4 mm and 7.27 mm in LVEDD; 5.45 mm and 5.34 mm in LVESD). Although T 4 -Irb showed significant decrease of LVESD and LA diameter compared with T 4 alone group, there was no significant difference in LV geometrical parameters between T 4 -Pro and T 4 alone ( Table 2) .
Ventricular functional changes: Doppler strain echocardiographic findings
T 4 alone showed significantly lower ejection fraction (EF) and FS compared with control, but within normal range (Table 2) . Also, peak systolic mitral annulus velocity (Sm) and LV S long was significantly impaired in T 4 alone compared with control ( Table 3 ). The two rats with significantly increased LV internal dimension showed markedly reduced EF and FS (57%, 58 % in EF and 26%, 28% in FS, respectively). Other eight T 4 rats showed more deteriorated S long (-16.32 ± 4.13%) despite comparable systolic function measured by EF (74.32 ± 3.67%) and FS (37.54 ± 2.21%) with control. T 4 -Irb showed significantly improved LV S long compared with Numeric data are expressed as the mean ± SD. Chi-square test for testing differences of categorical variables among four groups was performed. Statistical analysis of four continuous variables among four groups was performed using ANOVA, and P values < 0.05 were accepted as statistically significant. Turkey's post hoc test was used to make individual comparisons between groups when a significant change was observed with ANOVA.
Results
Induction of thyrotoxicosis
Administration of T 4 for 4 weeks significantly increased serum free T 4 and T 3 , HR and the ratio of heart weight (HW) to BW. The levels of T 3 and free T 4 were significantly increased with T 4 administration (T 4 alone; 25.3 ± 1.96 ng/mL and 5.62 ± 0.09 ng/dL, T 4 -Irb; 24.2 ± 0.72 ng/mL and 5.55 ± 0.10 ng/dL, T 4 -Pro; 24.9 ± 0.77 ng/mL and 5.48 ± 0.08 ng/dL vs. control; 5.5 ± 0.83 ng/mL and 2.78 ± 0.06 ng/dL, all P < 0.05). Also, the levels of TSH were significantly decreased by T 4 administration (T 4 alone; 0.72 ± 0.16 μU/mL , T 4 -Irb; 0.77 ± 0.14 μU/mL , T 4 -Pro 0.75 ± 0.12 μU/mL vs. control; 3.34 ± 1.26 μU/mL , P < 0.05). Although TSH was not sufficiently suppressed, T 4 administration for 4 weeks was effective at producing thyrotoxicosis in this model as previously described [14] .
Hemodynamic parameters
BW, HR and SBP at the beginning were the same in all groups of rats (Table 1) . After 4 weeks, T 4 alone showed significantly increased HR, HW and the HW/BW ratio and decreased BW compared with control (all P < 0.05) ( (Tables 2 and 3) .
Morphological Data
Cardiomyocyte analysis
Measurements of transverse fiber diameter (myocyte width) ranged from 18 μm (Control) to 27.5 μm (T 4 alone) ( Table 4) . T 4 alone promoted a significant increase in myocyte width compared with control (25.0 ± 1.77 vs. 18.8 ± 0.84 μm, P < 0.001). However, T 4 -Irb showed a significant decrease in myocyte width (21.0 ± T 4 alone and there were no significant differences in Sm and LV S long between control and T 4 -Irb. T 4 -Pro showed no differences in Sm with significant improvement of LV S long compared with T 4 alone ( Table 3) .
In terms of diastolic functions, although there was no significant difference in peak E velocity, peak A velocity was significantly increased in T 4 alone, T 4 -Irb and T 4 -Pro compared with control (Table 3, Fig. 3 ). Prolongation of DT (95.6 ± 3.06 vs. 82.0 ± 5.39 ms, P = 0.026), reduction of Ea velocity (4.34 ± 1.36 vs. 6.06 ± 1.74 cm/s, P < 0.001) and increase of E/Ea (21.5 ± 6.37 vs. 15.0 ± 6.87 cm/s, P = 0.003) were significantly prominent in T 4 alone compared with control (Fig. 3C) . T 4 alone showed significantly enlarged LA diameter (3.83 ± 0.11 vs. 3.45 ± 0.23 mm, P = 0.019) and mark- All values are presented as the mean ± SD; n, number of rats; T 4 , L-thyroxine; Irb, irbesartan; Pro, propranolol; E, peak E velocity; A, peak A velocity; DT, deceleration time; Ea, peak early diastolic mitral annular velocity; Sm, peak systolic mitral annular velocity; LV, left ventricular; S long, peak longitudinal strain; LA, left atrial. 
Interstitial connective tissue
To evaluate whether TH-induced cardiac hypertrophy was accompanied by cardiac fibrosis, we examined the presence of collagen fibers in the transverse sections. Corresponding Trichrome stains confirmed the presence of fibrosis. Compared with control, all samples of T 4 alone displayed marked inflammation and extracellular matrix fibrosis (Fig. 4) . T 4 -Irb showed significantly reduced number of inflammation foci and extent of fibrosis compared with T 4 alone. However, there were no significant changes between T 4 -Pro and T 4 alone (Table 4) . Cardiomyocyte width and LV S long in rats with fibrosis (n=9, 24.8 ± 1.79 and -14.4 ± 3.69) were significantly reduced compared with those in rats without fibrosis (n=11, 20.3 ± 1.82 % and -22.9 ± 4.02%, all P < 0.001). There was also a good correlation between changes in LV S long and presence of fibrosis (r = 0.76, P < 0.001) ( Table 5) . thyroid cardiomyopathy, because most hyperthyroid patients display diastolic dysfunction with conserved LVEF [19] . TH increases total blood volume and cardiac preload, but pacing-induced increase in contraction frequency generally reduces preload and stroke volume and increase of HR reduces diastolic filling time, leading to greater dependence on atrial systole [1] . The finding of unchanged LVEDD and increased indices of E/Ea in our thyrotoxic rats should be considered indicative of an effective increase in preload. Higher peak A velocity with reduction of E/A ratio and Ea velocity, and increase of E/Ea are evidence of the prominent diastolic dysfunction in thyrotoxic rats. Impairment in LV relaxation in thyrotoxic rats may result in reduction of early LA emptying, evidenced by low Ea. This impaired emptying contributes to a larger residual volume before LA contraction. The presence of such volumetric changes and increased LA pressure affects atrial structural and functional remodeling contractions, which becomes critically important during LV filling. Altered geometry such as enlarged LA diameter and increased LA pressure reduce longitudinal contraction, as suggested by the lower values of peak systolic strain of LA, which may have a potential impact on the development of atrial arrhythmias.
Although early stage hyperthyroid cardiomyopathy usually is associated with normal LVEF, radial shortening does not always guarantee normal LV systolic function [20] . In our study, eight of ten in T 4 alone rats showed more deteriorated LV S long despite similar EF and FS compared with control. Since longitudinal shortening is governed by longitudinal subendocardial fibers, which are more vulnerable to myocardial ischemia, assessment of LV longitudinal function based on strain echocardiography may be a sensitive marker for detecting subclinical alterations in LV systolic performance [20, 21] . Analysis with speckle tracking strain imaging measures wall motion velocities relatively irrespective of volume, contrary to EF, and has been validated for the evaluation of longitudinal LV function [21, 22] . Subclinical LV dysfunction relates to the structure-function relationship and can be detected by a decrease in longitudinal myocardial function, which occurs before the development of abnormality in conventional measures of LV performance [23] .
Role of irbesartan and propranolol in TH induced LV hypertrophy
Proposed causes of impairment in myocardial contraction and relaxation in TH-induced heart failure
Discussion
There were three key findings in this study. First, reduced LV systolic and diastolic function with myocardial hypertrophy and fibrosis was induced by TH. Second, although HR lowering treatment with propranolol improved LV systolic and diastolic function, it did not modify the TH-induced cardiac morphologic alterations, indicating specificity in the pathogenesis in thyrotoxic cardiomyopathy beyond tachycardia. Finally, even with onset of myocardial dysfunction, thyrotoxicosis rats treated with RAS blocker displayed near-normal LV systolic function with myocardial structure. These suggest that blocking of RAS expression, which is believed to be beneficial, can significantly attenuate TH-induced cardiac functional and structural remodeling, indicating a potential role of RAS in thyrotoxic cardiomyopathy.
Hyperthyroidism and cardiac function
Cardiovascular manifestations in hyperthyroidism occur frequently with various phenotypes, and the most common cause of hyperthyroidism, Graves' disease is frequently associated with pulmonary arterial hypertension, cardiac valve involvement, and autoimmune cardiomyopathy [18] . However, most cardiovascular hemodynamic effects of hyperthyroidism are independent of its cause and related both to the extent of TH excess and to its duration. TH has a consistent positive chronotropic effect, which increases the minute stroke work at any given level of cardiac preload with improved myocardial contractility and also increases the rate of myocardial relaxation, thus improving early cardiac filling [1] . However, it has yet to be established whether the impact of hyperthyroidism on cardiac preload actually contributes to the increased LV performance and controversy exists regarding LV systolic function in hyper- 0.90 ± 0.30 0.001 All values are presented as the mean ± SD; n, number; LV, left ventricular; S long, peak longitudinal strain; SR long , peak longitudinal strain rate; LA, left atrial ment, our thyrotoxic rat model is not associated with increase in SBP. These data indicate that factors other than hemodynamic changes play an important role in the pathogenesis of T 4 -induced cardiac hypertrophy [30, 31] , and clinical evidence suggests that blocking the actions of angiotensin II might confer protective benefits beyond lowering BP [32] . Although there is controversy regarding the formation of myocardial fibrosis induced by TH [33] [34] [35] , considering that RAS is activated in patients with hyperthyroidism [16, 17] and myocardial fibrosis depends on a complex relationship between stimulatory (including angiotensin II, endothelin I, catecholamines and aldosterone) and inhibitory factors acting on the collagen production [36] , it is reasonable to suggest that these mechanisms could mediate the increased myocardial fibrosis observed in our experimental data, suggesting the involvement of TH in regulating myocardial fibrosis. Interestingly, treatment with RAS inhibitor was presently able to prevent myocardial fibrosis. Crawford et al. [37] demonstrated that angiotensin II stimulates fibronectin and expression of collagen types I and IV in association with the proliferation of interstitial fibroblasts by direct action, which could be prevented by the AT1 receptor antagonist losartan. In the present study, altered myocardial function was induced by T 4 characterized with reduced LV systolic and diastolic function, and this was correlated with severity of myocardial hypertrophy, inflammation and fibrosis.
In conclusion, our results suggest that irbesartan could significantly attenuate structural and functional remodeling induced by experimental thyrotoxic cardiomyopathy, which is not found with propranolol, although regulation of HR is evident with adrenergic blocker. These results may implicate the RAS as having an important role in thyrotoxic cardiomyopathy beyond tachycardia.
